Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 4NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 15Other hematologic neoplasm 14Lymphoid 13Gynecologic 10Genitourinary 7Dermatologic 7CNS 7Plasma cell 5Other solid neoplasm 4Gastrointestinal 4Thoracic 3Head & Neck 2Breast 2Tumor-Agnostic 1Myeloid 1Classical hematology 1

Conditions

Tongue Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 38Radiotherapy 35Magnetic Resonance Spectroscopy 32Specimen Handling 22Cetuximab 18Fluorouracil 17Radiotherapy, Intensity-Modulated 16Platinum 161,2-diaminocyclohexaneplatinum II citrate 16Biopsy 15Paclitaxel 13Carboplatin 13Nivolumab 11Docetaxel 10pembrolizumab 8Radiation 8Fluorodeoxyglucose F18 8Erlotinib Hydrochloride 8Bortezomib 8Bevacizumab 8Gemcitabine 7Sorafenib 6Immunoglobulin G 6Disulfides 6aldesleukin 5Hydroxyurea 5Gefitinib 5Chemotherapy, Adjuvant 5(225)Ac-DOTA-c(RGDyK) 5cabozantinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Sirolimus × Head & Neck × Clear all
NCT01195922 2017-12-06

Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
37 enrolled 6 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Tongue Neoplasms

NCT01256385 2017-03-27

MAESTRO HN

National Cancer Institute (NCI)

Phase 2 Completed
86 enrolled 11 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡